We are live on ! Find out more
CYTR

CytRx Corp
CYTR

Delisted

CYTR was delisted on the 3rd of June, 2019.

Back to rankings

2 hedge funds and large institutions have $33K invested in CytRx Corp in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BMO
Beck Mack & Oliver
New York
+$33K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BMO
1
Beck Mack & Oliver
New York
$33K +$33K +33,500 New

CYTR Hedge Fund Activity: Q2 2021 in Review

2 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q2 2021, worth a combined $33K.

Buyers outnumbered sellers: 2 funds opened new CYTR positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Beck Mack & Oliver, opening a new position worth an estimated $33K.

  • 2 institutional investors held CytRx Corp (CYTR) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $33K of CytRx Corp stock for Q2 2021.
  • 2 funds opened new CytRx Corp positions in Q2 2021 and 0 closed out, a net change of +2 holders.
  • The largest CytRx Corp buyer in Q2 2021 was Beck Mack & Oliver, an estimated $33K added.

Based on aggregated 13F filings for Q2 2021.